East Asia & Pacific vs France: Current health expenditure
East Asia & Pacific
6.8%
in 2023
France
11.5%
in 2024
East Asia & Pacific rank
14th
France rank
13th
Current health expenditure over time
- East Asia & Pacific
- France
How they compare
France currently reports 11.5% against 6.8% in East Asia & Pacific, a difference of 4.7%.
That makes France's figure about 1.7 times East Asia & Pacific's.
Across all 24 years both countries report, France has been ahead every year.
East Asia & Pacific ranks 14th and France ranks 13th of 47 groups.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | East Asia & Pacific | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.1% | 10.3% | 4.2% | France |
| 2010s | 6.5% | 11.4% | 4.9% | France |
| 2020s | 6.9% | 11.9% | 5.0% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher current health expenditure, East Asia & Pacific or France?
- France, at 11.5% against 6.8% in East Asia & Pacific as of 2024.
- What is the difference in current health expenditure between East Asia & Pacific and France?
- 4.7%, with France ahead.
- How many years of comparable data are there for East Asia & Pacific and France?
- 24 years are reported by both, from 2000 to 2023.
- How do East Asia & Pacific and France rank globally for current health expenditure?
- East Asia & Pacific ranks 14th and France ranks 13th of 47 groups.
- Where does this data come from?
- Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as Current health expenditure (% of GDP). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Level of current health expenditure expressed as a percentage of GDP. Estimates of current health expenditures include healthcare goods and services consumed during each year. This indicator does not include capital health expenditures such as buildings, machinery, IT and stocks of vaccines for emergency or outbreaks.